[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [Benef](https://github.com/mm80843/T3.5/tree/main/docs/Benef/index.md) >> Individual ID:PBN__Benef_7 

# __Improved quantification capability__

## Name of the Benefit

Using reference materials and digital droplet PCR can improve the precision and comparability of SARS-CoV-2 quantification in wastewater, leading to more accurate surveillance data

## Description of actual returns pertaining to this benefit

* [Private investors in reference materials and digital droplet PCR technologies can benefit by providing essential tools for accurate quantification, which can lead to increased demand and potential collaborations.](https://github.com/mm80843/T3.5/blob/main/docs/BenefReturn/PBN__BenefReturn_7.md)

## Articles mentionning this Benefit

* [Presence of SARS-Coronavirus-2 RNA in Sewage and Correlation with Reported COVID-19 Prevalence in the Early Stage of the Epidemic in The Netherlands](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_1.md)

## Stakeholders benefitting from this Benefit

* [researchers](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_2.md)
* [laboratories](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_5.md)

## Risks which can benefit from this action

* [Quantification using reference materials and digital droplet PCR](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3.md)

